Modification  	Modification  	 NNP	B-NP
and  	and  	 CC	O
implementation  	implementation  	 NN	B-NP
of  	of  	 IN	I-NP
NCCN  	NCCN  	 NNP	I-NP
guidelines  	guidelines  	 NNS	I-NP
on  	on  	 IN	O
lymphomas  	lymphomas  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
Middle  	Middle  	 NNP	O
East  	East  	 NNP	O
and  	and  	 CC	O
North  	North  	 NNP	O
Africa  	Africa  	 NNP	O
region  	region  	 NN	O
In  	In  	 IN	O
the  	the  	 DT	O
Middle  	Middle  	 NNP	B-NP
East  	East  	 NNP	I-NP
and  	and  	 CC	I-NP
North  	North  	 NNP	I-NP
Africa  	Africa  	 NNP	I-NP
( 	( 	 -LRB-	O
MENA 	MENA 	 NNP	B-NP
)  	)  	 -RRB-	O
region 	region 	 NN	O
,  	,  	 ,	O
cancer  	cancer  	 NN	O
has  	has  	 VBZ	O
many  	many  	 JJ	O
epidemiologic  	epidemiologic  	 NN	B-NP
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
features  	features  	 NNS	I-NP
that  	that  	 WDT	O
are  	are  	 VBP	O
different  	different  	 JJ	O
from  	from  	 IN	O
those  	those  	 DT	O
in  	in  	 IN	O
the  	the  	 DT	O
rest  	rest  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
world 	world 	 NN	O
.  	.  	 .	O
Additionally 	Additionally 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
region  	region  	 NN	O
has  	has  	 VBZ	O
a  	a  	 DT	O
relatively  	relatively  	 RB	O
young  	young  	 JJ	O
population  	population  	 NN	O
and  	and  	 CC	O
large  	large  	 JJ	O
disparities  	disparities  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
availability  	availability  	 NN	O
of  	of  	 IN	O
resources  	resources  	 NNS	O
at  	at  	 IN	O
diagnostic  	diagnostic  	 JJ	B-NP
and  	and  	 CC	O
treatment  	treatment  	 NN	B-NP
levels 	levels 	 NNS	I-NP
.  	.  	 .	O
A  	A  	 DT	O
critical  	critical  	 JJ	B-NP
need  	need  	 NN	I-NP
exists  	exists  	 VBZ	O
for  	for  	 IN	O
regional  	regional  	 JJ	B-NP
guidelines  	guidelines  	 NNS	I-NP
on  	on  	 IN	O
cancer  	cancer  	 NN	B-NP
care 	care 	 NN	I-NP
,  	,  	 ,	O
including  	including  	 VBG	O
those  	those  	 DT	O
for  	for  	 IN	O
lymphoid  	lymphoid  	 JJ	B-NP
malignancies 	malignancies 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
panel  	panel  	 NN	O
of  	of  	 IN	O
lymphoma  	lymphoma  	 JJ	B-NP
experts  	experts  	 NNS	I-NP
from  	from  	 IN	O
MENA  	MENA  	 NNP	B-NP
reviewed  	reviewed  	 VBD	O
the  	the  	 DT	O
2009  	2009  	 CD	O
version  	version  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
NCCN  	NCCN  	 NNP	B-NP
Clinical  	Clinical  	 NNP	I-NP
Practice  	Practice  	 NNP	I-NP
Guidelines  	Guidelines  	 NNP	I-NP
in  	in  	 IN	O
Oncology  	Oncology  	 NNP	B-NP
( 	( 	 -LRB-	O
NCCN  	NCCN  	 NNP	B-NP
Guidelines 	Guidelines 	 NNP	I-NP
)  	)  	 -RRB-	O
on  	on  	 IN	O
Non-Hodgkin 	Non-Hodgkin 	 NNP	O
's  	's  	 POS	O
Lymphoma  	Lymphoma  	 NNP	B-NP
and  	and  	 CC	O
Hodgkin  	Hodgkin  	 NNP	B-NP
Lymphoma  	Lymphoma  	 NNP	I-NP
and  	and  	 CC	O
suggested  	suggested  	 VBD	B-NP
modifications  	modifications  	 NNS	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
region  	region  	 NN	O
that  	that  	 WDT	O
were  	were  	 VBD	O
discussed  	discussed  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
United  	United  	 NNP	B-NP
States  	States  	 NNPS	I-NP
NCCN  	NCCN  	 NNP	I-NP
Lymphoma  	Lymphoma  	 NNP	I-NP
Panels 	Panels 	 NNP	I-NP
.  	.  	 .	O
This  	This  	 DT	O
article  	article  	 NN	O
presents  	presents  	 VBZ	O
the  	the  	 DT	O
consensus  	consensus  	 NN	B-NP
recommendations 	recommendations 	 NNS	I-NP
.  	.  	 .	O
